Abstract Seasonal Influenza A virus (IAV) infections can promote dissemination of upper respiratory tract commensals such as Streptococcus pneumoniae to the lower respiratory tract resulting in severe life-threatening pneumonia. Here, we aimed to compare innate immune responses in the lungs of healthy colonized and non-colonized mice after IAV challenge at the initial asymptomatic stage of infection. Responses during a severe bacterial pneumonia were profiled for comparison. Cytokine and innate immune cell imprints of the lungs were analyzed. Irrespective of the colonization status, mild H1N1 IAV infection was characterized by a bi-phasic disease progression resulting in full recovery of the animals. Already at the asymptomatic stage of vir...
IntroductionInflammatory lesions after Influenza A viruses (IAV) are potential therapeutic target fo...
IntroductionInflammatory lesions after Influenza A viruses (IAV) are potential therapeutic target fo...
When a respiratory virus successfully infects the lungs, cascades of immune responses are initiated ...
Influenza A virus (IAV) is an extremely relevant human pathogen, infecting ~10% of the global popula...
Seasonal influenza epidemics pose a considerable hazard for global health. In the past decades, accu...
Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people....
Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people....
Secondary bacterial pneumonia following influenza infection is a significant cause of mortality worl...
Innate immune effectors constitute the first line of host defense against pathogens. However, the ro...
BACKGROUND: Influenza infections are often complicated by secondary infections, which are associated...
Influenza is a leading cause of respiratory disease worldwide. During pandemic and seasonal influenz...
Abstract Background Influenza infections are often complicated by secondary infections, which are as...
Influenza A viruses (IAVs) cause respiratory illness of varying severity based on the virus strains,...
International audienceDuring influenza A virus (IAV) infection, changes in the lung's physical and i...
IntroductionInflammatory lesions after Influenza A viruses (IAV) are potential therapeutic target fo...
IntroductionInflammatory lesions after Influenza A viruses (IAV) are potential therapeutic target fo...
IntroductionInflammatory lesions after Influenza A viruses (IAV) are potential therapeutic target fo...
When a respiratory virus successfully infects the lungs, cascades of immune responses are initiated ...
Influenza A virus (IAV) is an extremely relevant human pathogen, infecting ~10% of the global popula...
Seasonal influenza epidemics pose a considerable hazard for global health. In the past decades, accu...
Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people....
Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people....
Secondary bacterial pneumonia following influenza infection is a significant cause of mortality worl...
Innate immune effectors constitute the first line of host defense against pathogens. However, the ro...
BACKGROUND: Influenza infections are often complicated by secondary infections, which are associated...
Influenza is a leading cause of respiratory disease worldwide. During pandemic and seasonal influenz...
Abstract Background Influenza infections are often complicated by secondary infections, which are as...
Influenza A viruses (IAVs) cause respiratory illness of varying severity based on the virus strains,...
International audienceDuring influenza A virus (IAV) infection, changes in the lung's physical and i...
IntroductionInflammatory lesions after Influenza A viruses (IAV) are potential therapeutic target fo...
IntroductionInflammatory lesions after Influenza A viruses (IAV) are potential therapeutic target fo...
IntroductionInflammatory lesions after Influenza A viruses (IAV) are potential therapeutic target fo...
When a respiratory virus successfully infects the lungs, cascades of immune responses are initiated ...